Androgen deprivation therapy is a lifesaving therapy used by thousands of men each year, but some patients are warning of ...

Real-world data suggest that Erleada may offer an advantage over other treatment options for patients with metastatic ...

Explore the Global Prostate Care Market's growth, projected to reach USD 69.91 billion by 2031, driven by demographic shifts, tech advances, and the rising incidence of prostate conditions. Key ...

To close out Men’s Health Month, the Cancer Connections team sat down with Dr. William Dahut, the American Cancer Society’s ...

In Malaysia, prostate cancer has been the third-most common type of cancer among men since 2012, doctors caution.

During a live event, Jahan Aghalar, MD, discussed key NCCN-recommended oral therapies and landmark trials for metastatic ...

Metastatic prostate cancer is a type of cancer that began in the prostate gland and has spread to other areas of the body, ...

Bengaluru: Prostate cancer remains one of the most frequently diagnosed malignancies among men worldwide, including in India.

J&J is looking to add a hormone-sensitive indication to its prostate cancer therapy, which was originally approved in 2023.

DelveInsight’s Metastatic Prostate Cancer Pipeline report depicts a robust space with 80+ active players working to develop ...

Prostate cancer is one of the most common cancers in men, but when caught early, it's highly treatable. For Vernon Owens, a ...

Discover a study that explores the feasibility and benefits of aerobic versus resistance exercise for men undergoing prostate ...